Literature DB >> 17682581

Lactic acidosis in HIV patients receiving highly active antiretroviral therapy.

Y W Chow1, C L Leong, H L Chow, L S Hooi.   

Abstract

Exposure to highly active antiretroviral therapy (HAART) may lead to adverse effects related to mitochondrial toxicity such as lactic acidosis. We describe two cases of severe lactic acidosis in HIV-positive patients to illustrate the clinical symptoms and abnormal laboratory results associated with this condition. There is a lack of awareness about the risk factors for developing severe lactic acidosis and recognition of its onset with dire consequences.

Entities:  

Mesh:

Year:  2007        PMID: 17682581

Source DB:  PubMed          Journal:  Med J Malaysia        ISSN: 0300-5283


  4 in total

1.  Toxicities Associated With Metformin/Ritonavir Combination Treatment in Relapsed/Refractory Multiple Myeloma.

Authors:  Nitya Nathwani; Joycelynne Palmer; Timothy W Synold; Behrouz Salehian; Michael Rosenzweig; James F Sanchez; Samantha N Hammond; Kehinde Adekola; Valeria Tomarchio; Arnab Chowdhury; Chatchada Karanes; Myo Htut; Firoozeh Sahebi; Tanya Siddiqi; Amrita Krishnan; Stephen J Forman; Steven T Rosen
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2020-05-29

2.  8-Hydroxy-efavirenz, the primary metabolite of the antiretroviral drug Efavirenz, stimulates the glycolytic flux in cultured rat astrocytes.

Authors:  Maria Brandmann; Uwe Nehls; Ralf Dringen
Journal:  Neurochem Res       Date:  2013-10-04       Impact factor: 3.996

3.  A mathematical modelling study of HIV infection in two heterosexual age groups in Kenya.

Authors:  E O Omondi; R W Mbogo; L S Luboobi
Journal:  Infect Dis Model       Date:  2019-04-21

Review 4.  Cerebral Vascular Toxicity of Antiretroviral Therapy.

Authors:  Luc Bertrand; Martina Velichkovska; Michal Toborek
Journal:  J Neuroimmune Pharmacol       Date:  2019-06-17       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.